NPPGF yields 11.68% · PFE yields 6.13%● Live data
📍 NPPGF pulled ahead of the other in Year 1
Combined, NPPGF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NPPGF + PFE for your $10,000?
Nippon Gas Co., Ltd. engages in the supply and sale of LP gas and natural gas in Japan. It operates through LP Gas Business, Electricity Business, and City Gas Business segments. The company supplies LP gas through pipelines to homes built for sale, company dormitories, apartment buildings, other residential apartment complexes, as well as for commercial, industrial, agricultural, and automotive use; and high-pressure gas for commercial and industrial use. It also sells glass-top stoves, built-in stoves, gas oven ranges, gas rice cookers, dishwashers; gas water heaters, instant water heaters, floor heating products, bathroom heater/ventilation/dryer combo systems, and mist saunas; and commercial and industrial gas appliances. In addition, the company sells air-conditioning equipment, including gas and absorption heat pumps, cogeneration systems, and gas infrared heaters; remodeling-related equipment; and household equipment, as well as offers accident insurance agency services. Further, it engages in residential remodeling and consulting business; and the construction of gas, water supply, drainage, and air conditioning/heating equipment. Additionally, the company is involved in the electric power and gas business. Nippon Gas Co., Ltd. was founded in 1955 and is based in Tokyo, Japan.
Full NPPGF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.